In the latest trading session, Bristol Myers Squibb (BMY) closed at $49, marking a +1.22% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.09%.The the stock of biopharmaceutical company has risen by 4.22% in the past month, leading the Medical sector's gain of 2.17% and undershooting the S&P 500's gain of 7.21%.Market participants will be closely following the financial results of Bristol Myers Squibb in its upcoming release. The company is predicted to post an ...